Immunexpress Employee Directory

Immunexpress corporate office is located in 425 Pontius Ave N Ste 470, Seattle, Washington, 98109, United States and has 11-50 employees.

Employees by Department

Departments

Number of employees

Engineering & Technical

1

Sales

1

Medical & Health

1

Marketing

1

C-Suite

1

Operations

1

Finance

1

Immunexpress CEO

RB
United States flag for contact location.
Roslyn BrandonPresident & Chief Executive Officer
PhonePhoneEmailEmail
See Profile

Key Employees of Immunexpress

  • RD
    United States flag for contact location.
    Roy Davis

    Chief Medical Officer

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

Immunexpress Global Presence

globalPresence illustration
North America1-10
Australia1-10

Index of contact profiles from Immunexpress

Hundreds of professionals searching for Immunexpress have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at Immunexpress

Explore people who held key positions, contributed to Immunexpress's success, and advanced their careers.

People from Similar Companies in the Business Services Industry Located in Washington, United States

Frequently Asked Questions Regarding Immunexpress Employees

How many employees does Immunexpress have?
Immunexpress has 11-50 employees
Who is the CEO of Immunexpress?
Immunexpress’s CEO is Roslyn Brandon
Who are Immunexpress key employees?
Some of Immunexpress key employees are Roy Davis
Where is Immunexpress located?
Immunexpress’s headquarters are located at 425 Pontius Ave N Ste 470, Seattle, Washington, 98109, United States
How do I contact Immunexpress?
Immunexpress Contact Info: Phone number: (206) 858-6436 Website: www.immunexpress.com
What does Immunexpress do?

Immunexpress is a molecular diagnostic company, based out of Seattle, committed to improving outcomes for patients suspected of sepsis. Immunexpress' SeptiCyte® technology can assess a patient's dysregulated immune response by quantifying and analyzing gene expression from whole blood, providing actionable results in about an hour to guide the phys... ician in optimizing patient management decisions. SeptiCyte® RAPID is a lab test for sepsis that combines SeptiCyte® technology with the Biocartis' Idylla platform*, empowering clinicians to swiftly differentiate infection positive (sepsis) from infection negative systemic inflammation in patients suspected of sepsis; diagnosing bacterial sepsis, viral sepsis, or fungal infections. This powerful combination of technologies enhances certainty for early sepsis diagnosis, to improve clinical outcomes and lower healthcare costs. In March 2020, Immunexpress received CE Marking of SeptiCyte® RAPID and announced a commercialization partnership with Biocartis in Europe. In November 2021, Immunexpress received FDA clearance for SeptiCyte® RAPID. *Immunexpress is licensed to use the Idylla trademark from Biocartis NV.Read More

Is Immunexpress a public company?
Immunexpress is private company therefore does not currently have an official ticker symbol
See more information about Immunexpress Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.